Previous issue | Volume 84 | ESPE2015 | Next issue

54th Annual ESPE

Barcelona, Spain
01 Oct 2015 - 03 Oct 2015

Card image cap
Barcelona, Spain; 1-3 October 2015 Further information

Free Communications

Diabetes

RNA-Based MAFA Over-Expression is Sufficient to Drive Human Pancreatic Duct-Derived Cells Toward a [beta]-Cell-Like Phenotype
aUniversité Catholique de Louvain, Bruxelles, Belgium; bSan Raffaele Research Institute, Milan, Italy; cBroad Institute of Harvard and MIT, Cambridge, Massachusetts, USA; dJoslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA; ePediatric Endocrinology Unit, Cliniques Universitaires Saint Luc, Bruxelles, Belgium.
hrp0084fc3.1
Experience with Molecular Diagnosis in 48 Cases of Neonatal Diabetes Mellitus Using Targeted Next-Generation Sequencing
aEndocrinology Research Center, Moscow, Russia; bMorozovskaya Children City Clinical Hospital of the Moscow Healthcare Department, Moscow, Russia; cRussian Children Clinical Hospital, Moscow, Russia; dRepublican Children’s Clinical Hospital, Ufa, Russia
hrp0084fc3.2
Clinical Characteristics and Molecular Genetic Analysis of Six Patients with Pancreas Aplasia and Neonatal Diabetes: Predominance of PTF1A-Enhancer Mutations
aExperimental and Clinical Research Center, Charité Charité, Berlin, Germany; bInstitute for Experimental Paediatric Endocrinology, Charité, Berlin, Germany; cMax-Delbrück-Center for Molecular Medicine, Berlin, Germany; dDepartment of Pediatric Endocrinology, University Faculty of Medicine, Izmir, Turkey; eDivision of Pediatric Endocrinology, Children’s Hospital, Gaziantep, Turkey; fDepartment of Pediatrics, Istanbul Faculty of Medicine, Istanbul, Turkey; gChildren’s Hospital Hanau, Hanau, Germany; hExperimental Paediatric Endocrinology and Diabetes, Department of Paediatrics, Kiel, Germany; iUCL Institute of Child Health and Great Ormond Street Hospital for Children, London, UK
hrp0084fc3.3
Wolfram Syndrome: Natural History and Genotype-Phenotype Correlation Based on EURO-WABB Registry Show Gender Differences in Disease Severity
aBirmingham Children’s Hospital, Birmingham, UK; bUniversity of Birmingham, Birmingham, UK; cUniversity Hospitals Birmingham NHS Trust, Birmingham, UK; dINSERM - SC11, Paris, France; eIDIBELL, Hospital Duran i Reynals, Barcelona, Spain; fHospital Duran i Reynals, Barcelona, Spain; gUniversità degli studi di Padova, Padua, Italy; hNational eScience Centre, Glasgow, UK; iMedical University of Lodz, Lodz, Poland; jAlstrom Syndrome UK, Devon, UK; kUniversite Nice Sophia-Antipolis, Nice, France; lUniversitätsklinikum Münster, Munster, Germany; mUniversity of Melbourne, Melbourne, Australia; nTartu University Children’s Hospital, Tartu, Estonia; oH:S Bispebjerg Hospital, Copenhagen, Denmark; pUniversity of Copenhagen, Copenhagen, Denmark
hrp0084fc3.4
C-Peptide Levels and Glycaemic Control in Children, Adolescents, and Young Adults with Type 1 Diabetes
aDiabetes Center, A’Department of Pediatrics, P&A Kyriakou Children’s Hospital, Athens, Greece; bDepartment of Nuclear Medicine, Laiko General Hospital, Athens, Greece
hrp0084fc3.5
First Report of Nationwide Incidence and Prevalence of Type 1 Diabetes Among Children in Turkey
aGülhane Military Medical Academy, Ankara, Turkey; bGazi University, Ankara, Turkey; cKeçiören Education and Research Hospital, Ankara, Turkey; dKocaeli University, Kocaeli, Turkey; eTurkish Social Security Institute, Ankara, Turkey; fSchool of Women’s and Children’s Health UNSW Medicine, Syndey, Australia
hrp0084fc3.6